COVID-19 in patients with autoimmune diseases: characteristics and outcomes in a multinational network of cohorts across three countries. Tan, E. H., Sena, A. G., Prats-Uribe, A., You, S. C., Ahmed, W. U., Kostka, K., Reich, C., Duvall, S. L., Lynch, K. E., Matheny, M. E., Duarte-Salles, T., Bertolin, S. F., Hripcsak, G., Natarajan, K., Falconer, T., Spotnitz, M., Ostropolets, A., Blacketer, C., Alshammari, T. M., Alghoul, H., Alser, O., Lane, J. C. E., Dawoud, D. M., Shah, K., Yang, Y., Zhang, L., Areia, C., Golozar, A., Recalde, M., Casajust, P., Jonnagaddala, J., Subbian, V., Vizcaya, D., Lai, L. Y. H., Nyberg, F., Morales, D. R., Posada, J. D., Shah, N. H., Gong, M., Vivekanantham, A., Abend, A., Minty, E. P., Suchard, M., Rijnbeek, P., Ryan, P. B., & Prieto-Alhambra, D. Rheumatology (Oxford), 2021.
COVID-19 in patients with autoimmune diseases: characteristics and outcomes in a multinational network of cohorts across three countries [pdf]Paper  doi  bibtex   

Downloads: 0